# IntelliPharmaCeutics Corp., Etobicoke, Canada – FDA Inspections

Source: https://www.keypedia.com/companies/intellipharmaceutics-corp/78f18be2-f4f4-44f4-88d7-30d9f8f36ac5

> Inspection records and compliance data for IntelliPharmaCeutics Corp. in Etobicoke. 6 FDA inspections on record (1 OAI), 1 Form 483, last inspected September 26, 2022.

---

## Details

- Name: IntelliPharmaCeutics Corp.
- FEI Number: 3006370451
- Canada Business Number: 855997086NS0001
- Business Operations: FDF MANUFACTURE
- Address Line 1: 30 Worcester Rd
- City: Etobicoke
- Country Name: Canada
- Address: 30 Worcester Rd, Etobicoke, Canada
- Country: Canada

## Related Documents

- FDA Inspection 1190656 - IntelliPharmaCeutics Corp. - 2022-09-26 — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2022
- Canada Inspection - IntelliPharmaCeutics Corp. - Inspection #78710 - 2022-05-31 — source: Canada, date: May 31, 2022
- Canada Inspection - IntelliPharmaCeutics Corp. - Inspection #72355 - 2019-06-25 — source: Canada, date: June 25, 2019
- [483 - IntelliPharmaCeutics Corp. - 2019-06-14](https://www.keypedia.com/records/483/intellipharmaceutics-corp/403cc2b4-473f-41ed-aa24-59a66e7b0054) — source: FDA, date: June 14, 2019
- [FDA Inspection 1095607 - IntelliPharmaCeutics Corp. - 2019-06-14](https://www.keypedia.com/records/fda_inspections/intellipharmaceutics-corp/c33b77c0-b3fa-45f7-ae87-48a3ec032d64) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2019
- FDA Inspection 1027099 - IntelliPharmaCeutics Corp. - 2017-07-14 — source: FDA, date: July 14, 2017
- Canada Inspection - IntelliPharmaCeutics Corp. - Inspection #67849 - 2017-06-27 — source: Canada, date: June 27, 2017
- Canada Inspection - IntelliPharmaCeutics Corp. - Inspection #8171 - 2015-09-02 — source: Canada, date: September 2, 2015
- Canada Inspection - IntelliPharmaCeutics Corp. - Inspection #5471 - 2014-06-03 — source: Canada, date: June 3, 2014
- FDA Inspection 885403 - IntelliPharmaCeutics Corp. - 2014-05-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2014
- FDA Inspection 737274 - IntelliPharmaCeutics Corp. - 2011-07-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 23, 2011
- [FDA Inspection 698518 - IntelliPharmaCeutics Corp. - 2010-11-18](https://www.keypedia.com/records/fda_inspections/intellipharmaceutics-corp/d291354e-811b-499e-be41-64f468bb866b) — classification: Official Action Indicated (OAI), source: FDA, date: November 18, 2010

## Related Companies

- [Elysium Pharmaceuticals Limited](https://www.keypedia.com/companies/elysium-pharmaceuticals-limited/6249fc41-1206-431f-87ee-b7b13c89e8f4)
- [Stallion Laboratories Private Limited](https://www.keypedia.com/companies/stallion-laboratories-private-limited/20b4f144-435c-4f1c-8724-5ff1dca85264)
- [Italfarmaco S.p.A.](https://www.keypedia.com/companies/italfarmaco-spa/43c36cab-e301-4482-b9f7-b042cce56271)
- [Italfarmaco S.A.](https://www.keypedia.com/companies/italfarmaco-sa/1c87038a-ed84-4bfa-bb11-1fd51ce8eacd)
- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/e9d2de86-ad64-4278-8fb3-a8cd7909719e)
- [Teva Czech Industries s.r.o.](https://www.keypedia.com/companies/teva-czech-industries-sro/2a136d23-d81f-49b6-accf-a12f7e28c07b)
- [Afton Scientific, LLC](https://www.keypedia.com/companies/afton-scientific-llc/e5ec92fc-2eb5-4366-8d78-fd597c977fe8)
- [Pfizer Manufacturing Belgium NV](https://www.keypedia.com/companies/pfizer-manufacturing-belgium-nv/9251b625-0cd3-4c3e-8267-f0c88fe32d75)
- [Prime Matter Labs](https://www.keypedia.com/companies/prime-matter-labs/dddd6753-e267-4dbe-af3e-69350e9aab1c)
- [Ferndale Laboratories, Inc.](https://www.keypedia.com/companies/ferndale-laboratories-inc/0c6013f2-a6e7-41ff-a461-1e3fda056678)

## Related Officers

- [Manager](https://www.keypedia.com/people/qin-xu/176a88a7-a11e-4374-a64a-378806e76d84)
